3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000201:enzymology; D004298:Dopamine / Q000096:biosynthesis; D004347:Drug Interactions; D006801:Humans; D007700:Kinetics; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D013239:Stereotyped Behavior / Q000187:drug effects; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D010880:Piperidines; D011954:Receptors, Dopamine; C026539:preclamol; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine